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Spatial Distribution of the 
Cannabinoid Type 1 and Capsaicin 
Receptors May Contribute to the 
Complexity of Their Crosstalk
Jie Chen1,2,*, Angelika Varga1,3,*, Srikumaran Selvarajah1, Agnes Jenes1,3, Beatrix Dienes3, 
Joao Sousa-Valente1, Akos Kulik4,5, Gabor Veress6, Susan D. Brain7, David Baker8, 
Laszlo Urban9, Ken Mackie10 & Istvan Nagy1
The cannabinoid type 1 (CB1) receptor and the capsaicin receptor (TRPV1) exhibit co-expression 
and complex, but largely unknown, functional interactions in a sub-population of primary sensory 
neurons (PSN). We report that PSN co-expressing CB1 receptor and TRPV1 form two distinct sub-
populations based on their pharmacological properties, which could be due to the distribution pattern 
of the two receptors. Pharmacologically, neurons respond either only to capsaicin (COR neurons) or 
to both capsaicin and the endogenous TRPV1 and CB1 receptor ligand anandamide (ACR neurons). 
Blocking or deleting the CB1 receptor only reduces both anandamide- and capsaicin-evoked responses 
in ACR neurons. Deleting the CB1 receptor also reduces the proportion of ACR neurons without any 
effect on the overall number of capsaicin-responding cells. Regarding the distribution pattern of the 
two receptors, neurons express CB1 and TRPV1 receptors either isolated in low densities or in close 
proximity with medium/high densities. We suggest that spatial distribution of the CB1 receptor and 
TRPV1 contributes to the complexity of their functional interaction.
The capsaicin receptor, transient receptor potential cation channel, subfamily V, member 1 (TRPV1) is a non-selective 
cationic channel1. In addition to a series of exogenous molecules including capsaicin the pungent agent of chili 
peppers, TRPV1 is also directly activated, among other endogenous agents, by N-arachidonoylethanolamine 
(anandamide)2–4. Anandamide is also an endogenous ligand for the G protein-coupled cannabinoid (CB) type 1 
receptor2.
Nociceptive primary sensory neurons (PSN) constitute the prototypical cell type, which expresses TRPV11,5. 
Activation of TRPV1 results in cationic influx, subsequent depolarisation and action potential generation1,4. The 
CB1 receptor, reduces neuronal excitability6,7 through the activation of the G protein-coupled inwardly recti-
fying K+ channel and the inhibition of adenylyl cyclase and high voltage-activated Cav1.2, Cav2.1, and Cav2.2 
Ca2+ channels conducting L-type, P/Q-type, and N-type currents, respectively8–10. CB1 receptor activation 
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may also increase neuronal excitation through coupling to Gs or Gq/11, and the activation of adenylyl cyclase, 
phosphatidylinositol-3 kinase, and the mitogen-activated kinases, extracellular signal-regulated kinase 1 and 2, 
and p388–10.
The CB1 receptor and TRPV1 exhibit co-expression in various neurons including a major sub-population 
of PSN in dorsal root ganglia (DRG11–13 but see14,15). The anatomical arrangement between these two receptors 
allows a complex, but currently largely unknown, crosstalk that involves activation of both TRPV1 and the CB1 
receptor by anandamide.
In order to better understand how the CB1 – TRPV1 crosstalk shapes neuronal excitability, we herein inves-
tigated the functional interaction between the receptors, with particular attention to their spatial distribution in 
PSN and the effect of anandamide.
Results
Anandamide applied for 20 seconds at a concentration range (1 μ M, 3 μ M, 10 μ M and 30 μ M) known to induce 
excitation3,16 of cultured rat PSN, produced concentration-dependent inward currents at − 60 mV membrane 
potential with an EC50 of 2.2 μ M (Fig. 1A,B; Supplementary Table 1). The excitatory effect of anandamide was 
washed off within a few tens of seconds after stopping anandamide application (Fig. 1A,C). Anandamide at 30 μ M 
reached its maximal excitatory effect (Fig. 1B).
All the anandamide-responding neurons that were tested for capsaicin-responsiveness (Supplementary 
Table 2) produced currents to capsaicin applied at around its EC50 value (500 nM1,4), 2 minutes after anandamide 
superfusion (n = 29; Fig. 1C,D). However, a sub-population of neurons, while not responding to anandamide 
responded only to capsaicin (n = 10; Fig. 1E,F; Table 1 and Supplementary Table 2). Hence, anandamide- and 
capsaicin-responsiveness defined two sub-populations of PSN: the “anandamide-and-capsaicin-responsive” 
(ACR) and the “capsaicin-only-responsive” (COR) neurons (Fig. 1C–F).
The proportion of COR neurons in the overall sample of capsaicin-responsive cells was 25.6% (10 of 
the 39 cells; Table 1; Supplementary Table 2) and independent of anandamide concentration up to 30 μ M 
(Supplementary Table 2; p = between 1 and 0.6, Fisher’s exact test). The concentration of anandamide, applied 
before capsaicin application, did not have significant effect on the amplitude of capsaicin-evoked responses in 
ACR or COR neurons (data not shown; p = between 0.98 and 0.11, ANOVA). Therefore, we pooled the ampli-
tudes of capsaicin-evoked responses in ACR and COR neurons, respectively. The pooled capsaicin-evoked 
amplitudes were significantly different (ACR: − 3.19 ± 0.31 nA, n = 29; COR: − 0.96 ± 0.27 nA, n = 10; p = 0.002, 
Student’s t-test).
Since the anandamide concentration had no effect on either the proportion of responsive cells or the response 
to subsequent capsaicin application, we used anandamide at 30 μ M in the rest of the experiments.
TRPV1 is highly permeable to Ca2+ 1,4. Therefore, to confirm the presence of ACR and COR neurons, we stud-
ied changes in the intracellular Ca2+ concentration ([Ca2+]i) by anandamide (30 μ M) and capsaicin (500 nM) in 
rat cultured PSN grown for 16–22 hours.
Of the 98 KCl-responding neurons, 57 responded to capsaicin. Only 40 of the capsaicin-responsive neurons 
responded also to anandamide (Supplementary Figure 1). The ACR:COR neuron ratio was not significantly dif-
ferent from that found using whole-cell recordings (Table 1). The amplitude of the capsaicin-evoked calcium 
transients was significantly greater in ACR than in COR neurons (1.01 ± 0.12 in ACR (n = 40) and 0.49 ± 0.13 
(n = 17); Supplementary Figure 1; p = 0.015, Student’s t-test). The TRPV1 antagonist capsazepine (10 μ M) blocked 
the anandamide-evoked Ca2+ transients indicating that the anandamide-evoked excitatory effect is indeed medi-
ated through TRPV1 in PSN (Supplementary Figure 2).
Next we assessed 30 μ M anandamide- and 500 nM capsaicin-evoked changes in [Ca2+]i in PSN cultures pre-
pared from WT-TRPV1 and TRPV1−/− mouse DRG (Fig. 1G–I) to determine whether ACR and COR neu-
rons are also present in another species and the excitatory effects by both anandamide and capsaicin are indeed 
mediated exclusively through TRPV1. To verify chemosensitivity of PSN isolated from TRPV1−/− mice, we also 
administered mustard oil (50 μ M) following capsaicin application to the cells.
Responses of 136 KCl-responding WT-TRPV1 cells were analysed. Of these, 54 neurons responded to cap-
saicin, of which 37 were ACR and 17 were COR neurons (Fig. 1G,H; Table 1). The ACR:COR ratio was not sig-
nificantly different from that found with whole-cell recordings or Ca2+ imaging from rat cultured PSN (Table 1). 
The increase in [Ca2+]i induced by capsaicin was significantly smaller in COR neurons than in ACR cells (ACR: 
2.09 ± 0.13 (n = 37); COR: 0.81 ± 0.17 (n = 17); p < 0.0001, Student’s t-test).
Neither anandamide nor capsaicin increased the [Ca2+]i in the 126 TRPV1−/− neurons we assessed (Fig. 1I). 
However, 36 of the 126 neurons responded to mustard oil indicating that in general, chemosensitivity of the neu-
rons remained intact (Fig. 1I).
These data show that anandamide- and capsaicin-responsiveness are partially segregated in rodent PSN. 
Although we cannot categorically exclude the possibility that compensatory changes in TRPV1−/− mice con-
tribute to the lack of anandamide responsiveness, we suggest that both the anandamide- and capsaicin-evoked 
excitation depend on TRPV1 in PSN. Considering that TRPV1 mediates the excitatory effect of both capsaicin 
and anandamide, the behaviour of ACR and COR neurons is underlain by differential responsiveness of TRPV1 
to these agents in the two types of neurons.
The two main sub-populations of nociceptive PSN, the peptidergic and Bandeiraea simplicifolia lec-
tin (IB4)-binding cells17, exhibit different capsaicin-evoked responses18,19. However, our data indicate that 
the presence or absence of neuropeptides do not contribute to the partial segregation of anandamide- and 
capsaicin-responsiveness in PSN (Supplementary Table 3).
The CB1 receptor is able to regulate TRPV1 responsiveness16,20–27. Further, rimonabant at less than ~200 nM 
is a selective and specific CB1 receptor antagonist/inverse agonist28,29. Therefore, we used 200 nM rimonabant to 
determine whether the CB1 receptor contributes to the segregation of responses.
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Figure 1. Anandamide- and capsaicin-evoked responses are partially segregated in cultured primary 
sensory neurons. (A) A typical response to anandamide (10 μ M) recorded from cultured rat PSN by 
conventional whole-cell voltage-clamp. A sub-population of cells responds to anandamide. The response is 
washed off within a few tens of seconds after stopping anandamide application, which is indicated by the bar 
above the current trace. (B) Concentration-response relationship of anandamide in cultured rat PSN (data 
were fitted with Hill’s equation: y = Vmax*x^n/(k^n + x^n)). The calculated EC50 is 2.2 μ M; the maximal effect 
was reached at 30 μ M. (C,D) A typical whole-cell current from a cultured rat PSN during anandamide (bar, 
30 μ M) application. Capsaicin-evoked response from the same neuron (D). Bar indicates capsaicin (500 nM) 
application. A group of cultured PSN, which are regarded as “anandamide- and capsaicin-responsive” (ACR) 
neurons, exhibits this response pattern. (E,F) About a third of the rat PSNs are capsaicin-only-responsive 
neurons (COR). Typical whole-cell voltage-clamp recording from a COR neuron, which fails to respond to 
anandamide (E; bar, 30 μ M) but exhibits a response to 500 nM capsaicin (F). Bar indicates capsaicin application. 
(G) Changes in the intracellular Ca2+ concentrations were measured by a conventional ratiometric approach in 
cultured PSN isolated from wild type (WT) or TRPV1 knock out (TRPV1−/−) mice following the application of 
30 μ M anandamide (ANA), 500 nM capsaicin (CAP), 30 μ M mustard oil (MO), 50 mM KCl and 5 μ M ionomycin 
(ION). A typical recording of Ca2+ transients from a PSN which is isolated from a WT mouse and responds to 
both anandamide and capsaicin. (H) A typical recording of Ca2+ transients from a neuron which is isolated from 
a WT mouse and responds to capsaicin but not to anandamide. (I) Cells isolated from TRPV1−/− mice do not 
respond to either anandamide or capsaicin, however a sub-population of these neurons responds to mustard oil.
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First we used whole-cell voltage-clamp recordings from cultured rat PSN to facilitate comparison with 
data obtained in the first experiment (Table 1). Rimonabant, which was continuously superfused, did not 
change the ACR:COR neuron ratio (Fig. 2A; Table 1). However, interpretation of this finding requires caution 
Electrophysiology/Ca2+ imaging
Number of 
experiment Description of experiment
Total number 
of capsaicin-
responding 
neurons
Number of 
ACR neurons
Number of COR 
neurons Significant difference
1
Whole-cell recordings from 
rat cultured PSN in control 
bath solution
39 29 10
From No 2: p = 0.82 From No 3: 
p = 0.65 From No 5: p = 0.1 From 
No 6: p = 0.36 From No 7: p = 0.009 
From No 9: p = 0.28 From No 10: 
p = 0.4 From No 11: p = 1 From No 12: 
p = 0.08 From No 15: p = 1
2 Ca2+ imaging on rat PSN cultures 57 40 17
From No 1: p = 0.82 From No 3: p = 1 
From No 9: p = 0.07 From No 10: 
p = 0.11
3 Ca2+ imaging in WT-TRPV1 mouse PSN cultures 54 37 17 From No 1 p = 0.65 From No 2: p = 1
4 Ca2+ imaging in TRPV1
−/− 
mouse PSN cultures 0 n/a n/a n/a
5 Whole-cell recordings from IB4+ and IB4- cells 25 13 12
From No 1: p = 0.1 From No 6: 0.76 
From No 12: p = 0.8
6
Whole-cell recordings from 
rat cultured PSN in the 
presence of rimonabant
18 11 7 From No 1: p = 0.36 From No 5: p = 0.76 From No 12: p = 0.79
7 Ca2+ imaging in WT-CB1 mouse PSN cultures 124 113 11
From No 1: p = 0.009 From No 2: 
p = 0.0005 From No 3: p = 0.016
8 Ca2+ imaging in CB1
−/− 
mouse PSN cultures 115 74 41 From No 7: p < 0.0001
9
Ca2+ imaging in rat PSN 
cultures with a priori 
capsaicin application
197 161 36 From No 1: p = 0.28 From No 2: p = 0.07 From No 10: p = 0.71
10
Ca2+ imaging in rat PSN 
cultures with a priori 
capsaicin application and 
rimonabant application
237 190 47 From No 1: p = 0.4 From No 2: p = 0.11 From No 9: p = 0.71
11
Ca2+ imaging in rat PSN 
cultures with a priori 
capsaicin application and  
1 μ M NESS0237 application
34 25 9 From No 1: p = 1 From No 2: p = 0.81 From No 9: p = 0.35
12
Whole-cell recordings from 
rat cultured PSN for single 
cell PCR
56 31 25 From No 1: p = 0.08 From No 5: p = 0.8 From No 12: p = 0.79
Single-cell polymerase chain reaction
Number of 
experiment Description of experiment
CB1 receptor 
expression in 
ACR neurons
CB1 receptor 
expression in 
COR neurons
CB1 receptor 
expression in NR 
neurons
Significant difference
13 Single-cell PCR using RNA from rat cultured PSN 11/11 8/10 4/8 n/a
Immunofluorescent staining
Number of 
experiment Description of experiment
Total number 
of TRPV1-
expressing 
cells
Number of 
TRPV1 and 
CB1 receptor 
expressing 
cells
Significant 
difference
14 Immunofluorescent staining 150 149
From number 
of capsaicin-
responsive/CB1 
mRNA expressing 
cells in No 12: 
p = 0.87
Electron microcopy
Number of 
experiment Description of experiment
Total number 
of membrane 
patches 
analysed
Number of 
patches with 
high/medium 
receptor 
density
Number of patches 
with low receptor 
density
Significant difference from ACR/
COR ratio
15 Immuno- electron microcopy 18 14 4
From No 1: p = 1 From No 2: p = 0.76 
From No 9: p = 0.75 From No 12: 
p = 0.1
Table 1.  Number of cells found in different categories in various experiments. Significance values refer to 
the results of Fischer’s exact p value. Bold indicates significant difference.
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due to the relatively low number of neurons. Nevertheless, the amplitude of 30 μ M anandamide-evoked cur-
rents was significantly reduced from − 1.07 ± 0.33 nA (n = 7) to − 0.59 ± 0.18 nA (n = 11; Fig. 2B; p = 0.006, 
Student’s t-test; Supplementary Table 2) with rimonabant. Rimonabant significantly reduced the amplitude of 
the capsaicin-evoked responses in ACR neurons (from − 3.19 ± 0.31 nA (n = 29) to − 1.82 ± 0.40 nA (n = 11); 
p < 0.001, Student’s t-test) but not in COR neurons (− 0.96 ± 0.27 nA (n = 10) to − 0.54 ± 0.31 nA (n = 7), p = 0.34, 
Student’s t-test; Fig. 2C). Because of the high variability of data on COR neurons, interpretation requires caution. 
Nevertheless, these findings did suggest that the CB1 receptor might have a sensitising effect on capsaicin-evoked 
responses in ACR neurons, which might not be present in COR neurons. Subsequently, we conducted experi-
ments to confirm the CB1-mediated sensitising effect on TRPV1 and to study the underlying mechanisms.
First, to confirm the role of the CB1 receptor in sensitising TRPV1 in ACR neurons, we isolated PSN from 
Biozzi ABH (WT-CB1) and Biozzi ABH mice lacking the CB1 receptor (CB1−/−). We have chosen these mice, 
because they exhibit a significantly altered endocannabinoid system in comparison to C57BL/6 mice, and we used 
Biozzi ABH mice in previous studies30. Due to the significantly altered endocannabinoid system, we expected to 
find differences in TRPV1-mediated responses in C57BL/6 (background for TRPV1−/− mice) and Biozzi ABH 
mice if our hypothesis on the sensitising effect of the CB1 receptor on TRPV1 were correct. To increase the effi-
cacy of sampling, we again assessed changes in the [Ca2+]i.
Anandamide increased the [Ca2+]i in 113 of 230 KCl-responding neurons of WT-CB1 mice, all of which 
responded to capsaicin (Fig. 3A). In addition to the 113 ACR neurons, 11 of the 230 neurons exhibited responses 
only to capsaicin (Fig. 3A). The ACR:COR neuron ratio was significantly higher in WT-CB1 mice than in 
WT-TRPV1 mice or rats (Table 1). These data supports our view that the cannabinoid system contributes to reg-
ulating TRPV1 responsiveness. To get direct evidence for the involvement of the CB1 receptor, we next measured 
responses in PSN cultures prepared from CB1−/− mice.
The proportion of neurons responding to anandamide was significantly reduced within the total number of 
capsaicin-responding cells in CB1−/− mice (Fig. 3A; Table 1). At the same time, the proportion of COR neurons 
within the total number of capsaicin-responding neurons was significantly increased (Fig. 3A; Table 1). However, 
the overall proportion of neurons responding to 500 nM capsaicin in CB1−/− mice (115 of 200) was not statisti-
cally different to that in WT-CB1 mice (124 of 230, p = 0.56, Fischer’s exact test).
Deleting the CB1 receptor significantly reduced the amplitude of both anandamide (from 0.42 ± 0.03, 
n = 113, to 0.30 ± 0.03, n = 74, p = 0.02, Student’s t-test; Fig. 3B) and capsaicin-evoked responses (from 
0.56 ± 0.06, n = 113, to 0.39 ± 0.04, n = 74, p = 0.01, Student’s t-test; Fig. 3C) in ACR neurons. However, there 
was no significant difference in the amplitude of capsaicin-evoked responses between COR neurons isolated 
from WT-CB1 and CB1−/− mice (from 0.45 ± 0.11, n = 11, to 0.38 ± 0.04, n = 41, p = 0.42, Student’s t-test; 
Fig. 3C). These findings confirm that the CB1 receptor executes a sensitising effect on TRPV1, which increases 
Figure 2. Rimonabant reduces the amplitude of anandamide- and capsaicin-evoked currents only in ACR 
neurons without affecting the ratio of ACR and COR cells. (A) Whole-cell currents evoked by 30 μ M  
anandamide and subsequent 500 nM capsaicin applications were also recorded when 200 nM rimonabant 
(Rimo), a highly selective and specific antagonist/inverse agonist of the CB1 receptor was continuously applied 
to the cells through the bath solution in order to find the effect of the CB1 receptor on anandamide- and 
capsaicin-evoked responses in ACR and COR neurons. The presence of rimonabant in the bath solution does 
not change the ratio of ACR and COR neurons (p = 1, Fisher’s exact test). (B) Average maximum amplitudes 
of anandamide-evoked currents produced by cultured rat PSN in the control medium and in the presence of 
200 nM rimonabant (Rimo). Rimonabant significantly reduces the amplitude of anandamide-evoked currents 
(p = 0.006, Student’s t-test). (C) Average maximum amplitudes of capsaicin-evoked currents produced by 
ACR and COR type cultured rat PSN in control medium and in the presence of 200 nM rimonabant (Rimo). 
The average maximum amplitude of the capsaicin-evoked currents in COR type neurons is significantly 
smaller ($p = 0.002, Student’s t-test) than that in ACR type neurons in the control bath solution. While the 
presence of rimonabant significantly reduces the average maximum amplitude of capsaicin-evoked currents in 
ACR neurons (*p = 0.001, Student’s t-test), it has no significant effect on the average maximum amplitude of 
capsaicin-evoked currents in COR neurons (p = 0.34, Student’s t-test).
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capsaicin- and anandamide-evoked responses in ACR neurons. Further, these findings also indicate that in 
addition to sensitising TRPV1, the CB1 receptor also contributes to the partial segregation of anandamide- and 
capsaicin-responsiveness in PSN.
CB1 receptor activity can be evoked by endogenous ligands, such as anandamide, synthesised by a major 
proportion of TRPV1-expressing (hence CB1 receptor-expressing11,12) PSN27,31–33. Alternatively, the CB1 
receptor-mediated effects could be due to its constitutive activity28,34. To differentiate between these mechanisms, 
we next compared the effects on capsaicin-evoked responses of rimonabant, which blocks both evoked and con-
stitutive activity, and NESS032735, which only inhibits ligand binding. To exclude the possibility of CB1 recep-
tor activation by exogenous anandamide, capsaicin application was not preceded by anandamide superfusion. 
We assessed changes in the [Ca2+]i to increase efficacy and we applied 100 nM capsaicin to diminish TRPV1 
desensitisation36.
Capsaicin was applied 3 times consecutively with 2 minutes intervals to identify capsaicin responsive cells. 
The further application of 30 μ M anandamide revealed 161 ACR and 36 COR neurons in rat cultured PSN (Fig. 4; 
Table 1). This ratio was not significantly different from our previous findings with either whole-cell recordings 
or Ca2+ imaging from cultured rat PSN (Table 1). The average amplitudes of the first capsaicin-evoked responses 
in ACR neurons (1.07 ± 0.05, n = 161) was significantly greater than that in COR neurons (0.51 ± 0.07, n = 36; 
p < 0.0001, Student’s t-test; Fig. 4C,F).
100 nM capsaicin induced desensitisation in both ACR and COR neurons (Fig. 4A,C,D,F). Interestingly, the 
desensitisation was significantly greater in COR than in ACR neurons (Fig. 4A,C,D,F).
While rimonabant, applied immediately after the first capsaicin application until the end of the second cap-
saicin application (Fig. 4B,E), did not have any effect on the [Ca2+]i per se, it significantly increased the rate of 
reduction in the average amplitude of the second capsaicin-evoked responses in ACR (Fig. 4B,C; p = 0.0001, 
Student’s t-test) but not in COR neurons (Fig. 4E,F; p = 0.62, Student’s t-test). Although, several ACR neurons 
exhibited partial recovery in their capsaicin-evoked responses after stopping rimonabant application (Fig. 4B), 
the rate of reduction in the average amplitude of the third capsaicin-evoked responses in these cells was still sig-
nificantly greater when compared to that of the control experiment (Fig. 4C; p < 0.0001, Student’s t-test). No such 
differences were seen in COR neurons (Fig. 4F, p = 0.084; Student’s t-test). Notably, in addition to reducing the 
amplitude of the capsaicin-evoked responses in ACR cells, rimonabant also prolonged the recovery of responses 
in a group of both types of neurons (Supplementary Figure 3).
In contrast to rimonabant, NESS0327 at 100 nM per se substantially enhanced the duration of the 
capsaicin-evoked Ca2+ transients (Supplementary Figure 4A,B). This increase did not allow further assess-
ment in the great majority of cells (Supplementary Figure 4A,B). The [Ca2+]i-increasing effect was less pro-
nounced at 1 nM, and when NESS0327 was applied 30 seconds after stopping capsaicin application an apparently 
capsaicin-independent increase in the [Ca2+]i was produced (Supplementary Figure 4C). In this condition, 1 nM 
NESS0327 did not produce any effect on the amplitude of the second capsaicin application-evoked responses 
Figure 3. Deletion of the CB1 receptor reduces both anandamide- and capsaicin-evoked responses in ACR 
neurons and changes the ACR – COR ratio. (A) Conventional ratiometric approach was used to find the effect 
of deleting the CB1 receptor in Biozzi ABH mice on anandamide- and capsaicin-evoked calcium transients 
in ACR and COR type cultured PSN. The ratio of ACR and COR neurons in cultures prepared from wild type 
(WT-CB1) and CB1 receptor knock out (CB1−/−) mice. Deletion of the CB1 receptor significantly reduces the 
number of ACR neurons (p < 0.0001, Fisher’s exact test), whereas it significantly increases the number of COR 
neurons (p < 0.0001, Fisher’s exact test). The overall number of capsaicin-sensitive cells (ACR + COR) however 
is not changed significantly (p = 0.56, Fischer’s exact test, see Results). (B) Average amplitudes of anandamide-
evoked calcium transients in ACR neurons collected from wild type (WT-CB1) and CB1 receptor knock out 
(CB1−/−) mice. Deletion of the CB1 receptor results in a significant reduction in anandamide-evoked calcium 
transients (p = 0.02, Student’s t-test). (C) Average amplitudes of capsaicin-evoked calcium transients in ACR 
and COR neurons collected from wild type (WT-CB1) and CB1 receptor knock out (CB1−/−) mice. Deletion 
of the CB1 receptor results in significantly reduced amplitude of capsaicin-evoked calcium transients in ACR 
(p = 0.01, Student’s t-test) but not in COR neurons (p = 0.42, Student’s t-test).
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in COR neurons (n = 9; p = 0.74, Student’s t-test), whereas an increase was apparent in ACR neurons (n = 25; 
control: 94.66 ± 1.74% of the first response; NESS0327: 116.76 ± 9.52% of the first response; p = 0.0002, Student’s 
Figure 4. Capsaicin-evoked Ca2+ transients are significantly reduced by rimonabant in ACR but not in 
COR cultured rat PSN. (A) Conventional ratiometric approach was used to find the effect of the CB1 receptor 
antagonist/inverse agonist rimonabant (200 nM; RIMO) on capsaicin-evoked calcium transients in cultured 
rat PSN. (A) 100 nM capsaicin (CAP) was applied in every 2 minutes followed by 30 μ M anandamide (A) 
and 50 mM KCl. The recording shows calcium transients evoked by consecutive capsaicin application in an 
ACR type neuron in a control experiment when no rimonabant was applied. Capsaicin induces the typical 
desensitisation. (B) During the recording from another ACR type neuron, rimonabant (RIMO) was applied 
immediately after the first capsaicin application until the end of the second capsaicin application. Rimonabant 
reduces the amplitude of the Ca2+ transient evoked by the second capsaicin application (arrow). In this neuron, 
the capsaicin-evoked response exhibits partial recovery following the removal of rimonabant. (C) Average 
amplitudes of calcium transients evoked by consecutive application of 100 nM capsaicin in every 2 minutes in 
ACR type neurons either without (C; black bars) or with the application of 200 nM rimonabant (R; red bars). 
In control experiments capsaicin induces significant desensitisation (*p < 0.0001, Student’s t-test both for the 
second and third responses). Rimonabant produces a significant reduction in the amplitude of the calcium 
transients evoked by the second ($p = 0.0001, Student’s t-test) and third capsaicin ($p < 0.0001, Student’s t-test) 
applications. (D) Calcium transients evoked by consecutive capsaicin application in a COR type neuron (note 
the lack of response to anandamide). (E) Rimonabant (RIMO) has no effect on the amplitude of the Ca2+ 
transient evoked by the second capsaicin application in a COR neuron. (F) Average amplitudes of calcium 
transients evoked by consecutive application of 100 nM capsaicin in every 2 minutes in COR type neurons either 
without (C; black bars) or with the application of 200 nM rimonabant (R; red bars). In control experiments 
capsaicin induced desensitisation (*p < 0.0001, Student’s t-test). Rimonabant does not produce any significant 
change in the amplitude of the calcium transients evoked by the capsaicin applications.
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t-test; Supplementary Figure 4D,E). Although the excitatory effect of NESS0327 on PSN, the elucidation of which 
was not in the scope of the present study, makes interpretation of these findings very difficult, the lack of inhibi-
tory effect may suggest that ligand-induced activation of the CB1 receptor does not contribute to TRPV1 sensi-
tisation in PSN.
The finding that CB1 receptor inhibition or deletion has no effect on COR neurons may suggest that COR 
neurons might not express the CB1 receptor. To test this hypothesis, we next studied CB1 receptor expression in 
PSN by single-cell reverse transcription polymerase chain reaction (RT-PCR).
We collected 25 COR, 31 ACR and 20 cells, which did not respond to either of the TRPV1 activators (NR) 
from rat PSN cultures. The ACR:COR neuron ratio was not significantly different from the observation we made 
in whole-cell recordings from cultured rat PSN (Table 1). The amplitude of capsaicin-evoked responses was sig-
nificantly larger (p < 0.0001, Student’s t-test) in ACR (− 3.28 ± 0.35 nA, n = 31) than in COR (− 0.67 ± 0.06 nA, 
n = 25) neurons. RNA of 10 COR, 11 ACR and 8 NR cells were processed successfully with single-cell RT-PCR 
(i.e. the sample showed GAPDH mRNA expression; Fig. 5A,B).
CB1 receptor primers produced amplicons of the predicted size, whereas no amplicons were present when no 
template was included in the PCR mixture (Fig. 5A; Supplementary Figure 5). All ACR neurons (n = 11), eight of 
ten COR neurons, and four of eight NR neurons exhibited detectable CB1 receptor mRNA expression (Fig. 5B). 
Immunolabelling of cultured rat PSN using an anti-CB1 receptor and anti-TRPV1 antibody confirmed the high 
proportion of TRPV1-expressing cells also expressing the CB1 receptor (149 of 150, Table 1; Supplementary 
Figure 6).
For the control of immunostaining and assessing possible differences between the intact DRG and cul-
tured PSN, we also established the co-expression ratio of TRPV1 and the CB1 receptor in the intact DRG 
(Supplementary Figures 7 and 8). We found a slightly smaller proportion of TRPV1-expressing cells exhibiting 
obvious immunopositivity for the CB1 receptor in intact DRG than in PSN cultures (88.3 ± 3.8%, n = 3). This 
small difference could be due to culturing. Nevertheless, together, these findings indicate that the differing effects 
of rimonabant or deleting the CB1 receptor in ACR and COR neurons cannot be due to the exclusive expression 
of the CB1 receptor in ACR type neurons. Therefore, next we assessed the spatial distribution pattern of the CB1 
receptor and TRPV1.
Immunocytochemistry on SDS-digested freeze-fracture replicas (SDS-FRL) is a highly effective method 
to reveal sub-cellular protein distribution37. TRPV1-labelling, which served as a basis for selection of putative 
somatic membranes of PSN, was generally moderate to strong (Fig. 6A,B). All TRPV1-expressing membranes we 
examined exhibited immunolabelling for the CB1 receptor, which was also moderate to strong in general. Both 
TRPV1 and CB1 receptor immunoreactivities were specifically detected on the protoplasmic face (Fig. 6A,B). 
Virtually no labelling was observed on the exoplasmic face (Fig. 6A,B), which is in agreement with the epitope of 
both the anti-TRPV1- and anti-CB1 receptor antibodies raised against intracellular part of the respective mole-
cules (see Material and Methods).
Membrane patches co-expressing TRPV1 and CB1 receptors differed in receptor densities and distribution 
(Fig. 6A,B). Some of the patches exhibited only a few isolated receptors (Fig. 6A). The majority of the membrane 
Figure 5. The CB1 receptor is expressed by all ACR type and the majority of COR type cultured rat 
cultured PSN. (A) After determining the types of cultured rat PSN by whole-cell voltage-clamp recordings 
by anandamide (30 μ M) and capsaicin (500 nM) application, 76 cells were collected for single-cell PCR. 10 
COR type, 11 ACR type and 8 “anandamide- and capsaicin non-responding” neurons (NR) were successfully 
processed to find out whether the neuron expressed the CB1 receptor. The sizes of the amplicons generated 
to specific primers for CB1 receptor (127 bp) or the house-keeping molecule GAPDH (380 bp) were 
indistinguishable from the predicted sizes as it is shown by these typical gel images. L indicates the size marker. 
Note the presence of the GAPDH and the lack of CB1 amplicon in a COR neuron. (B) All the ACR cells and 8 
of 10 COR neurons express the CB1 receptor in this sample of neurons. In addition 50% of the non-responding 
cells also express the CB1 receptor.
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patches however exhibited a relatively high density of CB1 receptor expression, which was accompanied by mod-
erate to high TRPV1 receptor density (Fig. 6B). It is unlikely that the differences in densities could be due to major 
regional variation of receptor distribution within a single cell, because no such differences were evident by visual 
assessment of about 100 TRPV1 and CB1 receptor co-expressing cultured PSN neurons or PSN in intact DRG 
(Supplementary Figure 6 and Supplementary Figure 8).
We found that two, three or sometimes four immunoparticles labelling TRPV1 in these membranes often 
formed clusters (Fig. 6B). The distance of the gold particles in these clusters was between ~10 and ~55 nm 
(Fig. 6B). Although the majority of the CB1 receptors appeared solitary, some of them seemed to be in close 
vicinity (< ~55 nm) to TRPV1 (Fig. 6B).
We established morphometric data of 21 membrane patches (Table 2), which had an average size of 
5.20 ± 0.39 μ m2 and exhibited 2788 gold particles of which 1793 (85.38 ± 16.03, n = 21, on average) and 995 
(47.38 ± 6.78, n = 21, on average) labelled CB1 receptor and TRPV1, respectively. The densities for both recep-
tors varied in a wide range (Table 2) and the CB1 receptor density was significantly higher than that of TRPV1 
(p = 0.024, Student’s t-test). Correlations between some properties are shown in Supplementary Figure 9.
We also established the number of distances measured between each TRPV1 and its closest CB1 receptor 
neighbour as well as between each CB1 receptor and its closest TRPV1 neighbour, which were below 54.5 nm 
(Table 2). This threshold represents the maximum (“critical”) distance between the centres of the gold particles 
if the two receptors are positioned next to each other, and is based on the estimated size of the CB1 receptor, 
TRPV1, IgG and the gold particles38–41 (Table 2; Supplementary Figure 10A). The number of distances between 
each TRPV1 and the closest TRPV1 neighbour shorter than 56 nm, which represents the estimated maximum 
distance if TRPV1 molecules are located next to each other (Supplementary Figure 10B), was also established. The 
number of critical distances was then divided by the number the appropriate receptor in each patch.
Principal component analysis (PCA), an unsupervised multivariate statistical tool, which reduces the num-
ber of variables and maximises the variability of data, suggested the presence of 2 major groups and 3 outliers 
(Supplementary Figure 11). PCA’s loading plot suggested that the number of CB1 receptor – TRPV1 critical 
Figure 6. The SDS-FRL method reveals two major types of CB1 receptor and TRPV1 spatial distribution 
in DRG neurons. (A,B) Double immunogold labelling for TRPV1 (12 nm particles; arrows) and the CB1 
receptor (5 nm; arrowheads) reveals that the immunoreactivity for both proteins is moderate (A) to strong (B) 
on the protoplasmic face (P-face) but not on the exoplasmic face (E-face) of plasma membrane of PSN. In some 
patches of putative somatic membrane of PSN, the great majority of immunoparticles for TRPV1 and CB1 are 
isolated from each other (A), whereas on other patches of the membrane immunoparticles for TRPV1 and 
CB1 form co-clusters (arrow + arrowhead in B). Note the occasional co-clustering of particles labelling TRPV1 
(double arrows in B). Scale bars = 0.2 μ m.
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distances does not contribute significantly to the variability of data (not shown). After removing the outliers and 
non-significant variables, PCA identified three principal components (PCs) that together contributed to more 
than 80% of the variability. The PCA score plot suggested the presence of 2–4 groups of cells (Supplementary 
Figure 11).
To study the putative groupings in more details, we built a partial least square discriminant analysis (PLS-DA) 
model, which again suggested the presence of 3 PCs (Fig. 7A). The PLS-DA score plot clearly showed the sepa-
ration of three major groups (Fig. 7B). The loading plot (Fig. 7C) shows how, while the variable importance of 
projection plot (Fig. 7D) reveals the significance of, the various morphometric properties contributed to the 
separation of the membrane patches.
Neurons Membrane patches in Groups 1 (yellow in Fig. 7B) exhibited significantly smaller CB1 receptor den-
sities, larger TRPV1 – CB1 receptor average distances, and fewer TRPV1 – CB1 receptor critical distances than 
patches in Group 2 (red in Fig. 7B) and Group 3 (purple in Fig. 7B,E,F; Table 2). Patches in Group 2 were different 
from patches in Group 3 mainly in TRPV1 distribution (Fig. 7E,F; Table 2). Together these data indicate that the 
distribution of the CB1 receptor and TRPV1 enables an intensive crosstalk in a large proportion of PSN (Group 
2 and Group 3 neurons) and, due to the large distances between the two receptors, a limited crosstalk in a small 
group of neurons (Group 1). Importantly, the proportion of Group 1 – Group 2/Group 3 patches was not signifi-
cantly different from ACR – COR neuron proportion found in rat or C57BL/6 mice (Table 1).
The presence of a significant proportion of CB1 receptors and TRPV1 closer than 54.5 nm to each other in 
PSN suggests that the two receptors, similarly to the cornea26, could be engaged in protein-protein interaction. 
Therefore we next performed immunoprecipitation by either an anti-TRPV1 or an anti-CB1 receptor antibody 
followed by immunoblotting respectively with an anti-CB1 receptor or anti-TRPV1 antibody on protein samples 
isolated from rat DRG. We found in both experiments that the immunoprecipiated proteins contained the other 
molecule (Fig. 8).
Discussion
We applied a broad range of technologies to address the functional and structural interactions between the CB1 
receptor and TRPV1 in PSN. As a major finding, we provide data indicating that spatial distribution of the CB1 
receptor and TRPV1 is pivotal for the presence of two types of capsaicin sensitive PSN, the ACR and COR neu-
rons, which are differentiated by their sensitivity to anandamide.
Anandamide, in addition to TRPV1 and the CB1 receptor, also interacts with a series of other molecules10,42. 
These interactions could directly or indirectly induce cationic influx into sub-populations of PSN42–44. However, 
anandamide fails to increase the [Ca2+]i in PSN of TRPV1−/− mice, and the maximum 30 seconds application 
time we used is not enough for indirect anandamide-evoked activation42. Although we cannot exclude compen-
satory down-regulation of all anandamide-responsive proteins in TRPV1−/− mice, these findings strongly suggest 
that the excitatory effect of anandamide depends on TRPV1.
No of 
membrane 
patch
Number 
of CB1 
receptors
Number of 
TRPV1
Area of 
membrane 
patch (μm2)
TRPV1-
CB1 
average 
distance 
(nm)
CB1-
TRPV1 
average 
distance 
(nm)
TRPV1-
TRPV1 
average 
distance 
(nm)
Number of 
TRPV1-
CB1 critical 
distances
Number 
of CB1-
TRPV1 
critical 
distances
Number of 
TRPV1-
TRPV1 
critical 
distances
1 10 14 1.8 202.9 152.7 199.9 0 0 5
2 5 8 1.3 305.5 215 276 1 1 1
3 152 97 6.2 95.7 127.4 85.7 24 29 32
4 121 83 4 83.8 125.1 80.9 25 25 21
5 27 28 4.8 222.8 231.8 247.2 1 0 5
6 96 27 5.6 130.2 169.6 174.9 7 26 5
7 35 21 4.6 189.5 259.8 179.8 2 14 7
8 62 83 4.5 164 109.7 116 6 14 28
9 16 16 5.9 317.6 399.4 308.4 0 0 3
10 40 38 3 160.7 141.4 93.1 8 10 16
11 116 109 6.9 126.3 142.5 95.5 16 17 33
12 74 64 5.6 146 172.5 126.9 10 8 11
13 357 104 6.4 57.1 93.6 126.8 57 108 19
14 85 52 5 138.5 230 177.5 15 10 7
15 79 21 4.5 82.6 159.6 340.1 8 16 0
16 67 47 7.8 162.6 185.2 135.3 15 15 11
17 85 41 7.5 172.4 192.9 243.7 5 13 4
18 95 52 7.9 152.1 206.9 176.4 16 18 9
19 75 21 3.9 105 238.2 273.2 8 16 3
20 77 33 5.3 154.1 220.4 235.7 10 12 6
21 119 36 1.8 87 228.6 204 10 11 6
Table 2.  Morphometric data of primary sensory neurons examined with SSD-FRL electron microscopy.
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Figure 7. Morphometric analysis of electron microscopic images reveals three types of neurons. (A) Based 
on results of the multivariate statistical tool principal component analysis (PCA; see Supplementary Figure 11) 
we built a partial least square discriminant analysis (PLS-DA) model to find classify the groups found by PCA. 
PLS-DA identified three principal components which together accounted for ~80% of the variability of data. 
(B) The PLS-DA score plot reveals the presence of well-separated three groups of neurons. (C) The loading plot 
shows the contribution of the variables to the separation of the three groups. (D) The variable importance on 
projection plot shows that all variables contributed significantly to the separation of the groups. The contribution 
of TRPV1-CB1 average distance (TR-CB dist), TRPV1 density (TR dens) and CB1 receptor density (CB dens) is 
highly significant. TR-CB crit: number of TRPV1-CB receptor critical distances; TR-TR crit: number of TRPV1-
TRPV1 critical distances; TR-TR dist: TRPV1-TRPV1 average distance; CB-TR dist: CB1 receptor-TRPV1 
average distance. (E,F) Bar charts showing average values of morphometric data of neurons belonging to the 
three groups shown in (B). Statistical analysis (ANOVA followed by Fischer’s post-hoc test) shows that neurons 
is Group 1 (yellow) are different from neurons both in Group 2 (red) and 3 (purple) in CB1 receptor density 
(CB dens), TRPV1 – CB1 receptor average distances (TR-CB dist) and the number of TRPV1 – CB1 receptor 
critical distances (TR-CB crit). Neurons in Group 2 (red) are different from neurons in Group 3 (purple) mainly 
in the distribution of TRPV1 (TRPV1 density (TR dens); TRPV1-TRPV1 average distance (TR-TR dist) and the 
number of TRPV-TRPV1 critical distance (TR-TR crit)). CB1 receptor-TRPV1 average distances (CB-TR dist) 
are also different between neurons in Group 2 and 3. distribution. The number of CB1 receptor TRPV1 critical 
distances (CB-TR crit) is not different between the 3 groups.
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Cultured PSN that respond to capsaicin but not to anandamide have been described previously as a “very 
small proportion” of neurons22. Here we provide unambiguous evidence of pharmacologically distinct COR and 
ACR phenotypes in capsaicin-sensitive cultured PSN. We demonstrate that COR neurons constitute a significant 
proportion of cells, which does not depend on the length of culturing (at least between 16 and 74 hours), the order 
of anandamide or capsaicin application or the concentration of anandamide. However the findings that Biozzi 
ABH mice, which exhibit a significantly altered endocannabinoid system30, possess a significantly lower ratio of 
COR neurons than Sprague-Dawley rats or CB57BL/6 mice, and that deleting the CB1 receptor in Biozzi ABH 
mice reduces the proportion of ACR neurons, indicate that the ACR – COR ratio is affected by the endocannab-
inoid system.
Importantly, CB1 receptor deletion does not reduce the overall proportion of neurons responding to capsaicin. 
This finding indicates that while capsaicin-sensitivity is an inherent, anandamide-sensitivity is an acquired prop-
erty of native TRPV1. This behaviour of native TRPV1 is in stark contrast to heterologous TRPV1, which exhibits 
responsiveness both to capsaicin and anandamide without the CB1 receptor being expressed by the same cell3,45.
In addition to reducing the proportion of ACR neurons, deleting the CB1 receptor also reduces the ampli-
tude of capsaicin- and anandamide-evoked responses in ACR, but not in COR neurons. Rimonabant, which 
inhibits both constitutive and ligand-evoked CB1 receptor activation28,29, also reduces both anandamide- and 
capsaicin-evoked responses only in ACR neurons. However NESS0327, which blocks ligand-binding to the CB1 
receptor35, does not reduce responses in either cell types. Together these data, in agreement with recent findings23, 
indicate that the CB1 receptor, through its constitutive activity, produces a sensitising effect on TRPV1 in a sig-
nificant proportion of PSN.
Considering the sensitising effect of the CB1 receptor on TRPV1, deleting the CB1 receptor could reduce the 
number of ACR neurons through at least two mechanisms. First, due to the complete loss of the sensitising effect, 
anandamide-evoked responses could be reduced to below the detection threshold in a major proportion of ACR 
neurons. Alternatively, due to the loss of the protein-protein interaction, which is indicated by the results of our 
immunoprecipitation experiment, conformational changes, which could promote anandamide-responsiveness, 
are lost.
Deleting the CB1 receptor however, does not eliminate anandamide responsiveness. Therefore, mechanisms 
other than TRPV1 – CB1 crosstalk could also promote anandamide-responsiveness of TRPV1 in PSN. These 
may include TRPV1 sensitisation/promotion of anandamide-responsiveness by other metabolic receptors, or 
differing composition of the TRPV1 ion channel. Indeed, while the TRPV1 ion channel is functional either as a 
homo- or heterotetramer39,40,46–49, and the SDS-FRL immunolabelling is highly effective in revealing molecules37, 
we found the great majority of TRPV1 molecules to be in isolation in a group of neurons. However, analysis of 
morphometric data indicate that the number of TRPV1-TRPV1 critical distances might not play a major role in 
defining ACR or COR phenotype.
Figure 8. TRPV1 and the CB1 receptor are engaged in PSN. Immunoblots showing TRPV1/CB1 receptor 
heteromers in the rat DRG. Whole cell lysates were prepared from DRG and immunoprecipitation assays 
using anti-CB1 (A) and anti-TRPV1 (B) antibodies were carried out as detailed in Materials and Methods. 
The resulting immune complexes were analysed by immunoblotting using anti-TRPV1 (A) and anti-CB1 (B) 
antibodies. Immunoprecipitating antibodies and immunoblotting antibodies were omitted from positive and 
negative controls, respectively. TRPV1 was detected as a ~100 kDa band, while the CB1 receptor was detected as 
a doublet with molecular weight ~55 and ~63 kDa in the immunoprecipitated samples.
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Rimonabant increases the time-course of recovery when changes in the [Ca2+]i are used to assess respon-
siveness to capsaicin. However, no similar effect of rimonabant can be observed when responses are assessed by 
measuring whole-cell currents. Therefore, this rimonabant-evoked effect could be due to the reduced inhibitory 
effect of the CB1 receptor on voltage-gated Ca2+ channels8,9,10 rather than a reduced inhibitory effect on TRPV1.
NESS0327 at 1 nM increases the amplitude of capsaicin-evoked Ca2+ transients in ACR neurons, which may 
also suggest that an inhibitory effect is produced in these cells by CB1 receptor activity evoked, for example, by 
anandamide synthesised by sub-populations of PSN31–33,27. However, NESS0327 per se increases the [Ca2+]i in 
capsaicin-responding cells. Therefore, in addition to reduced CB1 receptor-mediated inhibition of TRPV1, direct 
or indirect effects of Ca2+ permeable channels or blocking Ca2+ sequestration could also underlay this effect.
The lack of a significant CB1 receptor-mediated inhibitory effect on TRPV1 is surprising because a series of 
reports confirms this effect16,20–22,24–26. However, the anandamide-induced and CB1 receptor-mediated inhibitory 
effect on TRPV1 is evident at low nM anandamide concentration16,24,25. Therefore, it is reasonable to assume that 
the downstream effects of anandamide on the CB1 receptor may depend on the concentration of this agent, and 
only the low nM anandamide-evoked CB1 receptor signalling can overcome the constitutive activity-mediated 
sensitising effect.
While our single-cell RT-PCR experiments show that all ACR and the majority of COR neurons express the 
CB1 receptor, the use of rimonabant or the deletion of the CB1 receptor reduces responses only in ACR neurons. 
Therefore, differing spatial distribution pattern of the two molecules could underlay different responses in the 
two types of neurons. Morphometric data indeed reveals the presence of three distinct distribution patterns of 
TRPV1 and CB1 receptors on membrane patches of PSN. Membrane patches belonging to two groups (Group 2 
and Group 3; Fig. 7B), which differ from each other mainly in the distribution of TRPV1, express the two recep-
tors in medium/high density and proximity, whereas a smaller group of patches (Group 1; Fig. 7B) expresses the 
receptors in low density and in isolation. This latter group is differentiated from the rest of the patches by its low 
CB1 receptor density and the low number or absence of TRPV1-CB1 receptor critical distances. Importantly, our 
functional studies also suggest that spatial proximity of TRPV1 and the CB1 receptor could be responsible for the 
anandamide-responsiveness-promoting effects of the CB1 receptor on TRPV1, explaining the presence of ACR 
and COR neurons. Further, the proportion between ACR and COR neurons and neurons expressing the receptors 
in high density and close proximity and in low density and isolation are statistically insignificant. Based on these 
considerations, it is reasonable to hypothesise that neurons expressing the two receptors in high density and close 
proximity could be associated with the ACR, whereas those expressing the two receptors in low density and in 
isolation could be COR in phenotype.
In summary, our data demonstrate that the CB1 receptor sensitises TRPV1 and promotes anandamide-responsiveness 
of TRPV1 in a major sub-population of capsaicin-sensitive PSN, and that spatial proximity of the two molecules may 
underlay these effects. The sensitising and anandamide-responsiveness-promoting effects in PSN are of particular 
importance because TRPV1 in these neurons is pivotal in the development of pain in peripheral pathologies50,51, 
whereas activation of the CB1 receptor by anandamide in PSN has an analgesic effect52,53. Therefore, increasing 
anandamide levels through the inhibition of anandamide hydrolysis by fatty acid amide hydrolase (FAAH) has 
been suggested as a novel means to control pain associated with peripheral pathologies53–55. Our present findings 
however, indicate that increased tissue levels of anandamide, which seems to have limited TRPV1 desensitising 
effect56, could significantly reduce the potential analgesic efficacy of FAAH inhibitors. Therefore, in order to utilise 
the analgesic potential of endogenous anandamide fully in PSN, ways to interfere with the mechanisms, through 
which the CB1 receptor promotes anandamide-responsiveness and sensitisation of TRPV1, must be identified. 
Due to the co-expression of TRPV1 and the CB1 receptor in various areas of the brain13, the CB1 receptor – 
TRPV1 crosstalk we characterised in the present study could also have relevance in brain signal processing.
Methods
All procedures were performed in accordance with the UK Animals (Scientific Procedures) Act 1986, the revised 
National Institutes of Health Guide for the Care and Use of Laboratory Animals, the Directive 2010/63/EU of the 
European Parliament and of the Council on the Protection of Animals Used for Scientific Purposes and the guide-
lines of the Committee for Research and Ethical Issues of IASP published in Pain, 16 (1983) 109–110. Further, 
we obeyed to Good Laboratory Practice and ARRIVE guidelines. All procedures on animals were approved by 
veterinary services (Central Biological Services) at Imperial College London, UK. Every effort was taken to min-
imize the number of animals used.
Drugs. The following drugs were used in this study: capsaicin (500 nM or 100 nM, Tocris, UK); anan-
damide (1 mM to 30 μ M, Tocris), rimonabant (200 nM, NIH, USA), mustard oil (50 μ M; Sigma), NESS0327 
(1nM and 100nM, Cayman Chamicals) and ionomycin (5 μ M, Sigma). Anandamide was dissolved in ethanol 
then the stock solution was prepared with Tocrisolve (Tocris). Capsaicin, rimonabant, mustard oil, NESS0327 and 
ionomycin stock solutions were prepared in DMSO. The final DMSO dilution was equal or less than 1:2000. The 
minimum final Tocrisolve and ethanol dilutions were ~1:106 and 1:500, respectively. In control experiments, none 
of the vehicles at their maximum concentration produced any responses (data not shown).
Animals. Forty four male Sprague-Dawley rats (80–200 g) and nine wild type (five C57BL/6 × 129SvJ 
(WT-TRPV1) and 4 Biozzi ABH (WT-CB1) and five TRPV1−/− and four CB1−/− mice (with C57BL/6 × 129SvJ 
and Biozzi ABH background for TRPV1−/− and CB1−/−, respectively) were housed in climate-controlled rooms, 
on a 12 h light/dark cycle and with food and water ad libitum. All mice were male and between 20 and 25 g. 
Animals were terminally anaesthetised by isoflurane or CO2, and decapitated.
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Cell culturing. Dorsal root ganglia from the C1 to the S1 segment were dissected and placed into Ham’s 
nutrient F12 culture medium (Sigma, UK) supplemented with 1 mM L-glutamine (Invitrogen, UK), 5000 IU/ml 
penicillin (Invitrogen, UK), 5000 μ g/ml streptomycin (Invitrogen, UK) and 2% ultroser G (Biospectra, France). 
Ganglia were incubated in type IV collagenase (Lorne Diagnostics, UK, 300 U/ml) for 3 hours at 37 °C at 5% CO2. 
Following several washes in the supplemented culture medium, ganglia were triturated with fire-polished Pasteur 
pipettes, and plated on poly-DL-ornithine (Sigma, UK)-coated glass coverslips in the supplemented medium. 
Cells were grown in the supplemented medium in the presence of 50 ng/ml nerve growth factor (NGF, Promega, 
USA) for16–72 hours.
Electrophysiology. Cells attached to coverslips were placed into a recording chamber and superfused with a 
bath solution (1–2 ml/min). Borosilicate glass micropipets (4–6 MΩ) were pulled on a DMZ automated electrode 
puller (DMZ, Germany). Conventional whole-cell voltage-clamp recordings were done from neurons of 15–30 μ m 
in diameter using an Axopatch 200B amplifier, Digidata 1200 digitizer and the pClamp 8 software package 
(Molecular Devices, USA) with a respective sampling and filtering rate of 1 kHz and 5 kHz at 37 °C. The holding 
potential was − 60 mV.
The bath and pipette solutions contained (concentrations in mM) NaCl 150, KCl 5, MgCl2 2, CaCl2 2, HEPES 
10, glucose 10, and NaCl 5, KCl 150, MgCl2 2, HEPES 10, EDTA 1, respectively. The pH of both the bath and 
pipette solutions was adjusted to pH7.4. Drugs were applied in the bath solution through a small plastic tube (i.d. 
0.5 mm) that was placed within ~100 μ m from the cell from which the recording was done. Drug application was 
controlled by the pClamp8 software package, and anandamide and capsaicin were applied two minutes apart. In 
some experiments neurons were incubated it fluorescein isothiocyanate -conjugated IB4 to identify one of the 
main sub-populations of nociceptive primary sensory neurons.
Ca2+-imaging. For assessing changes in the [Ca2+]i, primary sensory neurons cultured for 1–3 days were 
loaded with Fura-2 acetoxymethyl ester (Fura-2 AM, 5 μ M; Molecular Probes, Inc., Eugene, OR) in the presence 
of 2 mM probenecid (Molecular Probes) for 60 minutes at 37 °C in a HEPES-buffered saline (in mM): NaCl 122; 
KCl 3.3; CaCl2 1.3; MgSO4 0.4; KH2PO4 1.2; HEPES 25; glucose 10; adjusted with NaOH to pH 7.4. Coverslips 
were placed in a laminar flow perfusion chamber (Warner Instrument Corp., UK) and superfused with extra-
cellular solution (in mM: NaCl 160; KCl 2.5; CaCl2 1; MgCl2 2; HEPES 10; glucose 10; pH 7.4) continuously via 
a six-channel perfusion system. The following test solutions were applied to the cells: anandamide (30 μ M, for 
30 seconds), capsaicin (100 nM for 15 seconds, or 500 nM for 30 seconds), mustard oil (50 μ M for 30 seconds; 
Sigma) and KCl (50 mM for 30 seconds). The outlet of the perfusion system was positioned next to the group 
of neurons from which the recordings were obtained. In some experiments, ionomycin (5 μ M, Sigma) was also 
used as control for maximally increasing the intracellular calcium concentration at the end of the recordings. 
Application of drugs was controlled manually. Experiments were performed at 37 °C. Only one field of view was 
tested on each coverslip.
Imaging was performed on either of two systems. Images of Fura-2 loaded cells with the excitation wavelength 
alternating between 340 or 355 and 380 nM were captured with a Peltier element-cooled slow scan charge-coupled 
device camera system (PTI, NJ, USA or optiMOS, QImiging, Canada). Following subtraction of the background 
fluorescence, the ratio of fluorescence intensity at the two wavelengths as a function of time (rate 1 Hz) was cal-
culated automatically (R = F340/F380 or R = F355/F380) either by the ImageMaster 5.0 software package (PTI) 
or the WinFlour software package (Dr Dempster, Strathclyde University, UK). Data were further analysed by the 
pClamp 10 software package (Molecular Devices, USA).
Single-cell polymerase chain reaction. Following whole-cell voltage-clamp recordings, neurons were 
collected by drawing them into large bore electrodes made from borosilicate glass capillaries. Each cell was then 
placed in RT-PCR tubes with 3 μ l 3.3x RT-PCR buffer, 5 μ l nuclease free water and sonicated for 60 s. The 3.3x 
RT-PCR buffer consisted of 5x First Strand Buffer (66 μ l), 10 mM dDNTP Mixture (16.5 μ l), 3 μ g/μ l Random 
Primers (4 μ l) and nuclease free water (13 μ l). One μ l DTT (Invitrogen, USA), 0.5 μ l Superscript II (Invitrogen, 
USA) and 0.5 μ l RNase inhibitor (Promega, USA) were then added to each tube and the RNA was reverse tran-
scribed into cDNA at 37 °C for 2 hours. cDNA produced was then stored at − 20 °C.
Each cDNA sample was used for 30 cycles of GoTaq DNA polymerase (Promega)-catalysed PCR with primers 
designed to amplify the CB1 receptor and GAPDH cDNA. The sequences of the primers were as follows: CB1 receptor 
forward 5′-TCCATAGAGAAGGGTATTGATAGAAT-3′ and reverse 5′-TTTGTAGCTGTGAGAAGAGGTG-3′ 
expected size 127 bp, and GAPDH forward 5′  -GGTGAAGGTCGGAGTCAACG-3′  and reverse 
5′-CAAAGTTGTCATGGATGACC-3′ , expected size 380 bp. The PCR reaction mixture contained cDNA, forward 
and reverse primers, 1 mM MgCl2, 1× Green Go-Taq Reaction buffer (Promega), 0.2 mM deoxynucleotide mix 
(Promega) and 1.25 U Go-Taq DNA polymerase (Promega). Each amplification cycle consisted of denaturation at 
95 °C for 30 s, annealing at 57 °C for 60 s. PCR products were then used as a template for a second round reaction 
for the CB1 receptor using the same primers and conditions. Products were separated on 2% agarose gel by electro-
phoresis and visualized by ethidium bromide. Signals were analyzed with the Syngene software.
Combined immunofluorescence staining. Cultured rat PSN attached to the coverslips were washed 
with PBS and fixed by 4% paraformaldehyde in 0.01 M PBS (pH 7.4) for 10 minutes. Intact lumbar DRGs were 
collected following transcardial perfusion of terminally anaesthetised rats and mice by 4% paraformaldehyde. DRGs 
were post-fixed in 4% paraformaldehyde, washed in 0.01 M PBS and cut into 10 mm sections. Blocking with 10% 
bovine serum albumin was followed by incubating the cells and sections with an anti-TRPV1 (AB5370P, Chemicon, raised in 
rabbit against 21 amino acids of the C terminus (TGSLKPEDAEVFKDSMVPGEK), diluted at 1:1000) and an anti-CB1 
receptor (Prof. K. Mackie, raised in goat against 72 amino a ci ds ( SK DL RH AF RS MF PS CE GT AQ PL DN SM GD SD C
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L HK HA NN TA SM HR AA ES CIKSTVKIAKVTMSVSTDTSAEAL) of the C terminus, diluted at 1:8000; Veress 
et al. 2014) antibody overnight, at 4 °C. Staining was visualised by secondary antibodies conjugated with Cyanine 3- 
and CFTM488A-conjugated secondary antibodies. Coverslips were mounted on glass slides and sections were 
covered with Vectashield containing DAPI (Vector Laboratories, UK) and examined using an LSM 510 META 
confocal laser scanning microscope (Zeiss, Oberkochen, Germany). The specificity of the TRPV1 antibody were 
tested on rat DRG sections (Supplementary Figure 12A) and CB1 receptor knock out mice57.
Sodium dodecyl sulfate (SDS)-digested freeze-fracture replica immunolabeling. Immunohisto- 
chemical labeling for electron microscopy was performed as described previously37. Briefly, adult (150–
200 g) male Sprague-Dawley rats (n = 4) were anesthetized with sodium pentobarbital (50 mg/kg, i.p.), 
and perfused transcardially with 25 mM PBS, followed by 2% paraformaldehyde and 15% saturated picric 
acid in 0.1 M phosphate buffer (PB). Sections from DRGs were cut at a thickness of 110 μ m. The slices were 
cryoprotected in a solution containing 30% glycerol in 0.1 M PB and then frozen by a high-pressure freez-
ing machine (HPM 100; Leica, Austria). Frozen samples were inserted into a double replica table and frac-
tured into two pieces at −130 °C and replicated by carbon deposition (5 nm thick), platinum (2 nm), and 
carbon (15 nm) in a freeze-fracture replica machine (BAF 060; BAL-TEC, Lichtenstein). They were digested in 
a solution containing 2.5% SDS and 20% sucrose in 15 mM Tris-HCl at 80 °C for 18 h then at 60 °C for 18 h. 
The replicas were washed in 25 mM PBS containing 0.05% bovine serum albumin (BSA; Roth, Germany) 
and then incubated in a blocking solution containing 5% BSA for 1 h. Subsequently, replicas were incubated 
in a mixture of primary antibodies (TRPV1 raised in guinea pig against the 22 amino acids of the C termi-
nus (YTGSLKPEDAEVFKDSMVPGEK; Neuromics, USA), the dilution was 1:1000 and CB1 receptor (Prof. K. 
Mackie, raised in goat; Veress et al. 2014), dilution was 1:4000) in 50 mM Tris-buffered saline (TBS) contain-
ing 1% BSA. After several washes, replicas were reacted with a mixture of gold-coupled donkey anti-guinea pig 
(for TRPV1; 12 nm) and rabbit anti-goat (for CB1, 5 nm) secondary antibodies (1:30; BioCell Research 
Laboratories, Cardiff, UK) in 25 mM TBS containing 5% BSA. The anti-TRPV1 antibody from Neuromics pro-
vided better staining in the replicas than then the anti-TRPV1 antibody from Chemicon, which we tried in a pilot 
study. They were then washed and picked up on 100-mesh grids. The specificity of the antibodies was tested on 
tissues dissected from TRPV1 and CB1 knock out mice57,58.
Immunoprecipitation. Rat DRGs were homogenized in ice-cold NP40 buffer (Thermo Fisher Scientific, 
Rockford, IL) supplemented with 1 mM PMSF (phenylmethylsulfonyl fluoride; Sigma-Aldrich, St. Louis, MO) 
and protease inhibitor cocktail (Sigma-Aldrich) in a HT mini homogenizer (OPS Diagnostics, Lebanon, NJ) 
using zirconium beads (OPS Diagnostics). Homogenates were sonicated twice for 10 sec each and agitated con-
stantly for 2 hours at 4 °C. Lysates were centrifuged for 20 minutes at 12,000 rpm at 4 °C. The protein concentration 
of the supernatant was determined by BCA assay (Thermo Fisher Scientific).
Immunoprecipitation of 350–500 μ g cell lysate was carried out overnight with 2 μ g rabbit anti-CB1 
(H-150; Santa Cruz Biotechnology, Heidelberg, Germany) that was raised against the 150 amino acids 
o f the C terminus of the human CB1 receptor ( MK SI LD GL AD TT FR TI TT DL LY VG SN DI QY ED I
K GD MA SK LG YF PQ KF PL TS FR GS PF QE KM TA GD NP QL VP AD QV NI TE FY NK SL SS FK EN EE NI-
 QC GE NFMDIECFMVLNPSQQLAIAVLSLTLGTFTVLENLLVLCVILHSRSLRC). The specificity of this antibody 
was studied by Western blotting on brain tissues isolated from CB1 knock out mice (Supplementary Figure 12B). In 
another experiment, the immunoprecipitation was done by a goat anti-TRPV1 (P-19; Santa Cruz Biotechnology) anti-
body. The specificity of this antibody was shown previously59. In addition we also studied the specificity by Western 
blotting (Supplementary Figure 12C). Samples were constantly agitated at 4 °C. Immunoprecipitating antibodies were 
omitted from negative controls (mock control). Antibody/antigen complexes were then precipitated with 20 μ l protein 
A/G PLUS agarose (Santa Cruz Biotechnology) for 2 h at 4 °C. Agarose/antibody complexes were collected by cen-
trifugation at 2500 rpm for 5 minutes and the pellet was washed four times in ice-cold PBS supplemented with 1 mM 
PMSF and protease inhibitor cocktail. The bound antigen was eluted in 2x concentrate dithiothreitol-containing 
sample buffer by heating to 50 °C for 10 min. The anti-TRPV1 and anti-CB1 receptor antibodies we used for immu-
noprecipitation provided better signal to noise ration than the antibodies used for immunolabelling.
Immunoprecipitated samples and whole cell lysates (40–60 μ g protein; input) were analysed on 10% SDS 
polyacrylamide gel under reducing conditions. Immunoblotting was carried out using goat anti-TRPV1 (P-19; 
Santa Cruz Biotechnology; 1:750) or goat anti-CB1 (K-15; Santa Cruz Biotechnology; 1:1000) primary antibod-
ies. Appropriate secondary antibodies were purchased from Santa Cruz Biotechnology. Immunoreactive bands 
were visualised b y the SuperSignal West Pico Chemiluminescent Substrate (Thermo Fisher Scientific) using a Gel 
Logic 1500 Imaging System (Kodak, Tokyo, Japan). The specificity of the K-15 anti-CB1 receptor antibody was 
assessed by Western blotting using tissues from WT and CB1−/− mice (Supplementary Figure 12D).
Data analysis and statistics. Whole-cell recordings were analysed with the ClampFit 8.0 software pack-
age. Cells were regarded as anandamide- or capsaicin-responsive if the drug application-associated change in the 
current exceeded 50 pA.
Calcium imaging data were analysed by a custom-made Microsoft Excel macro, which following visual 
inspection of the time-Δ ratio (340/380 or 355/380) line chart, automatically measures the peak amplitude of the 
calcium transients produced by each drug. An increase of more than 10% in the 340/380 (or 355/380) ratio, if it 
was visibly associated with drug application, was regarded as a response. Based on previous data27, 2.5 times of 
the standard deviation of the amplitude of the baseline noise equals with a maximum of 9.5–10% increase in the 
340/380 (or 355/380) ratio.
Comparison of KCl-evoked increase in the [Ca2+]i in capsaicin-sensitive neurons isolated from WT-CB1 and 
CB1−/− mice revealed that deletion of the CB1 receptor significantly reduces the depolarisation-induced changes in 
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the [Ca2+]i (from 0.73 ± 0.04 (n = 122) to 0.48 ± 0.02 (n = 112), p < 0.0001, Student’s t-test). Therefore, we compared 
the absolute values of anandamide- and capsaicin-induced changes in [Ca2+]i in all calcium imaging experiments.
Electron microscopic morphometric data were analysed by PCA followed by PLS-DA. PCA is an unsuper-
vised multivariate statistical tool which transforms a large number of variables into a smaller number of uncor-
related variables known as PCs. PCA generates clusters the separation of which is enhanced by PLS-DA. PLS-DA 
itself is a supervised classification tool which rotates PCA component to achieve the largest separation. PLS-DA 
also provides the information on the variables which contribute the most to the separation.
The normality of data was checked by the Kolgomorov-Smirnov test. Data obtained by the same drug application 
were averaged. The effects of various treatments were compared with paired or unpaired one-tailed or two-tailed 
Student’s t-test, analysis of variances (ANOVA) followed by Fisher’s post-hoc test, or by two-sided Fisher’s exact test 
as appropriate. Differences were regarded significant at p < 0.05. In Results, the exact p values are given unless it is 
less than 0.0001. In this latter case, p values are indicated as p < 0.0001. Data are expressed as mean ± standard error 
of mean; “n” refers to the number of cells or cultures used in the same measurements as indicated.
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